• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Supporting Musculoskeletal Health: Tending to Muscles, Joints, and Bones

    2023 Contract Manufacturing Survey

    Dosage and Delivery Innovations Help Manufacturers Meet Common Challenges

    A Paradigm Shift for Antioxidants?

    Manufacturing Dietary Supplements in Economic Uncertainty
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    GOOD Meat Receives FDA Go-Ahead for Cultured Meat

    IFF Achieves Industrial-Scale Production of Anaerobic Probiotic Strain

    Jones Healthcare Group Primed to Help Nutraceutical Brands Comply with New Packaging Rules

    Nordic Naturals Debuts Probiotic Line in More Than 375 Sprouts Farmer’s Markets

    DolCas Biotech's Curcugen Featured in Beauty-From-Within Supplement
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    GOOD Meat Receives FDA Go-Ahead for Cultured Meat

    IFF Achieves Industrial-Scale Production of Anaerobic Probiotic Strain

    Nordic Naturals Debuts Probiotic Line in More Than 375 Sprouts Farmer’s Markets

    DolCas Biotech's Curcugen Featured in Beauty-From-Within Supplement

    NOW Tests Bromelain Supplements Purchased on Amazon
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    GOOD Meat Receives FDA Go-Ahead for Cultured Meat

    IFF Achieves Industrial-Scale Production of Anaerobic Probiotic Strain

    Jones Healthcare Group Primed to Help Nutraceutical Brands Comply with New Packaging Rules

    Nordic Naturals Debuts Probiotic Line in More Than 375 Sprouts Farmer’s Markets

    DolCas Biotech's Curcugen Featured in Beauty-From-Within Supplement
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Nordic Naturals Debuts Probiotic Line in More Than 375 Sprouts Farmer’s Markets

    DolCas Biotech's Curcugen Featured in Beauty-From-Within Supplement

    NOW Tests Bromelain Supplements Purchased on Amazon

    Podcast: Erin Stokes, ND, on Natural Health Strategies and the Role for Dietary Supplements

    'What’s Up With Supps' Event at Expo West Raises Over $8,000 for Vitamin Angels
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Gencor

    KLK OLEO

    JRS Pharma

    Verdure Sciences

    Nutrition21, LLC
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Gencor

    KLK OLEO

    JRS Pharma

    Verdure Sciences

    Nutrition21, LLC
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    California’s COVID Misinformation Law, AB 2098, Spurs Fight Over Physician Freedom of Speech

    The law sets a troubling precedent for anything outside the relatively narrow scope of conventional medical consensus.

    California’s COVID Misinformation Law, AB 2098, Spurs Fight Over Physician Freedom of Speech
    By Erik Goldman, Holistic Primary Care02.16.23
    There’s a battle raging in California over physician freedom of speech, and the outcome has national implications. At issue is Assembly Bill No. 2098 (AB 2098)—a new California law aimed at stopping the spread of COVID-19 “misinformation” and “disinformation.” AB 2098 passed the California legislature last summer and was signed by Governor Gavin Newsom in September. It deputizes the state’s medical and osteopathic boards to take disciplinary action—including revocation of licenses—against MDs and DOs who spread what the bill defines as COVID-related mis- or disinformation.

    The bill designates dissemination of misinformation or disinformation related to COVID-19 as “unprofessional conduct,” and points to prior statutes giving the state’s boards the power to “take action against any licensed physician and surgeon who is charged with unprofessional conduct.”

    This is clearly intended to target doctors who question or criticize federal and state vaccine policies. AB 2098 states: “The safety and efficacy of COVID-19 vaccines have been confirmed through evaluation by the federal Food and Drug Administration (FDA),” and that “The spread of misinformation and disinformation about COVID-19 vaccines has weakened public confidence and placed lives at serious risk.”

    But it is based on a very broad definition of misinformation that could be interpreted to include any modality that contradicts “scientific consensus” or falls outside current “standards of care.”  Consequently, AB 2098 has ramifications far beyond California, and far beyond COVID.

    Other states including Colorado, Washington, and New Mexico, are considering bills similar in intention and design. So far, none have progressed as far as California’s, which passed the state’s senate by 32-8, and the state assembly by 56-20.

    A Significant Victory

    Advocates for medical freedom of speech won a significant, if limited, victory in late January when Senior U.S. District Judge William Shubb issued a preliminary injunction that hinders the implementation of California’s law.

    Shubb’s decision came in response to two lawsuits that were among several cases challenging the constitutionality of AB 2098. The injunction stops the state—at least temporarily—from taking further disciplinary action against the doctors named in the suit, as well as physician members of two organizations also named as plaintiffs: Physicians for Informed Consent (PIC) and Robert F. Kennedy Jr.’s Children’s Health Defense (CHD).

    But in a separate case in a different district, Judge Fred Slaughter denied a preliminary injunction on the same statute.

    Beyond COVID-19, Beyond California

    At this point, you may be thinking, “I’m a busy natural products executive. Why should I be worried about some local law that really only affects anti-vax doctors in wacko California?”

    There are several reasons to be concerned.

    For one, if allowed to stand, AB 2098 sets a troubling precedent for anything outside the relatively narrow scope of conventional medical consensus. Many, if not most therapies and products used routinely by holistic and functional medicine physicians—including herbs and nutraceuticals—fall outside the bounds of conventional practice standards.

    If AB 2098 or similar statutes in other states are to be enforced, then physicians who discuss non-pharma options with patients could potentially run afoul of their state boards and be subject to disciplinary action.

    Even something relatively simple and benign as a vitamin D recommendation for immune support could potentially be construed as “misinformation” under the standards set by AB 2098. The California law may not be specifically intended to punish practitioners who recommend supplements, but that could be an unintended consequence.

    Secondly, there is a significant overlap between practitioners who question COVID-19 vaccines, and those who recommend a lot of supplements and nutrition-based therapies. Regulators could use advocacy of supplements as a red flag signaling that a practitioner warrants closer scrutiny. The law may be intended to curb COVID-specific misinformation, but it sets precedents that could potentially be applied more broadly.

    Thirdly, AB 2098 and other laws like it are likely to have a squelching effect on practitioner-patient communications. If doctors fear they could lose their licenses simply for informing patients about non-conventional alternatives, they are much less likely to have such discussions.

    Obviously, that could have a negative impact on companies that depend on practitioner referrals to drive sales.

    But it also has broader civil liberties implications. As patients, we rely on medical practitioners for guidance and insight based on their clinical experience and their understanding of the science. At least that’s how it’s supposed to be. If doctors do not feel free to discuss all options and share their perspectives, we all suffer.

    Even if one agrees that misinformation is a serious threat to public wellbeing and that it needs to be curtailed, the use of “scientific consensus” as the sole measure of whether something is or is not “misinformation” should strike you as highly problematic.


    “Would the medical boards responsible for enforcing consensus and punishing misinformation under a law like AB 2098 be able to keep up with the quick changes in scientific opinion? Should physicians who are early adopters of a viewpoint that later becomes ‘consensus’ be punished for their forward thinking?”


    ‘Consensus’ Can Change

    “The most obvious problem with AB 2098 is the bill’s assumption that a term like ‘scientific consensus’ is a specific enough guideline for tracking and punishing misinformation by medical professionals. This is a particular problem for topics relating to COVID-19; there may be consensus in a rough sense, but the finer details often remain contentious,” wrote Zach Caverley, PA, a physician assistant specializing in cardiology.

    In a well-reasoned article in City Journal, a leading publication on urban planning and policy, Caverley noted that, “Scientific ‘consensus’ is an ever-shifting designation,” one that can change suddenly.

    “A scientific consensus can be overturned abruptly by new evidence of better quality. A daily aspirin was a mainstay of heart-attack prevention for decades, until an update by the US Preventive Service Task Force advised that the overall benefit of this practice was negligible. The USPSTF also updated the age guidelines for breast-cancer screening—a move that professional societies hotly contested even after the printing of the final recommendations in 2016.”

    Would the medical boards responsible for enforcing consensus and punishing misinformation under a law like AB 2098 be able to keep up with the quick changes in scientific opinion? Should physicians who are early adopters of a viewpoint that later becomes “consensus” be punished for their forward thinking?

    Critics of AB 2098 contend that the answer to both questions is clearly “No.” Judge Shubb, presiding over the Eastern District of California, strongly agreed.

    “The provision is unconstitutionally vague,” Judge Shubb stated when issuing a preliminary injunction to AB 2098 in January. Shubb’s move will prevent the state from moving forward with disciplinary action against several California physicians who had been designated under the law as spreaders of misinformation.

    “Because COVID-19 is such a new and evolving area of scientific study, it may be hard to determine which scientific conclusions are ‘false’ at a given point in time.”

    Constitutional Challenges

    There are at least four lawsuits challenging the constitutionality of AB 2098.

    In one case (Høeg, et al. v. Newsom, et al.), five licensed California physicians, with the support of The New Civil Liberties Alliance—a non-profit group that views “the administrative state” as a threat to constitutional freedoms—sued California’s governor and representatives of California’s medical boards, contending that AB 2098 violates their First Amendment rights to free speech, and their Fourteenth Amendment rights to due process under the law.

    In a separate suit (Hoang v. Bonta), osteopath Letrinh Hoang, DO—along with Physicians for Informed Consent and Children’s Health Defense—sued the state attorney general, Rob Bonta, and Osteopathic Medical Board head Erika Calderon, on First and Fifth Amendment grounds.

    “The Board has no right to declare information false just because it is against the scientific consensus and the ‘standard of care,’” the Hoang complaint stated.

    The suit also argued that patients have a constitutional right to hear information from physicians even if it is outside consensus viewpoints, and that physicians also have a constitutional right to recommend or prescribe off-label uses of various medications, so long as they duly inform patients about the FDA status of the treatments and the fact that the recommendations are outside consensus opinions.

    In issuing his preliminary injunction, Shubb affirmed that the plaintiffs in the Hoang and Høeg cases have the standing to bring a legal challenge against AB 2098.

    A Protracted Battle Ahead

    Rick Jaffe, Esq, the attorney who represented Dr. Hoang, and who has argued other high-profile medical freedom cases, considers Shubb’s injunction to be a significant victory. But he said the legal battle over AB 2098 is likely to continue.

    “I expect the AG’s office to appeal because Judge Slaughter in the Central District … denied a preliminary injunction on the same statute,” Jaffe noted. He expects that the state’s medical boards will seek out “some workarounds … to undercut the impact of Judge Shubb’s opinion.”

    In a special webinar on the AB 2098 situation, sponsored by Holistic Primary Care and the United Natural Products Alliance (UNPA), Jaffe said he believes he was able to prevail in obtaining an injunction owing to an expert declaration by cardiologist Sanjay Verma, MD.

    Verma, a spokesman for Physicians for Informed Consent, one of the plaintiffs in the Hoang case, provided a 40-page document chronicling the numerous and often sudden changes in scientific consensus across many areas of medicine over the decades. This helped convince Shubb that “contemporary scientific consensus” shouldn’t be the primary measure for defining “misinformation,” especially in a rapidly changing situation like the COVID-19 pandemic.

    The Hoang and Høeg suits had the support of the American Civil Liberties Union, among other free speech groups. Two additional lawsuits challenging AB 2098 are pending before the Ninth Circuit Court of Appeals. 

    It remains to be seen whether Newsom or the California attorney general will push for implementation of this controversial and politically-charged law.

    Newsom has said little publicly about AB 2098, though in his official signing statement last fall, he acknowledged that he is “concerned about the chilling effect” a law like this could have on physicians.

    Despite those concerns, he said he signed AB 2098 because he views it as “narrowly tailored to apply only to those egregious instances in which a licensee is acting with malicious intent or clearly deviating from the required standard of care while interacting directly with a patient.”

    Clearly, many people disagree with Newsom’s assessment that this law is “narrowly tailored.”


    "Everyone in the natural products industry ought to pay close attention to what’s happening in California. It may not seem imminently threatening to your own life or business. But seen in the context of broader efforts to squelch dialog about non-prescription alternatives, and to limit the public’s access to supplements, the fight over AB 2098 is definitely cause for concern."


    A National Agenda

    The language of AB 2098 draws heavily from a July 2021 public statement from the Federation of State Medical Boards (FSMB) which posited that:

    “Due to their specialized knowledge and training, licensed physicians possess a high degree of public trust and therefore have a powerful platform in society, whether they recognize it or not. They also have an ethical and professional responsibility to practice medicine in the best interests of their patients and must share information that is factual, scientifically grounded and consensus-driven for the betterment of public health. Spreading inaccurate COVID-19 vaccine information contradicts that responsibility, threatens to further erode public trust in the medical profession and puts all patients at risk.”

    FSMB is a national oversight organization representing 71 state-level medical and osteopathic boards. It is a co-sponsor of the U.S. Medical Licensing Examination.

    California Assemblymember Evan Low, the author of AB 2098, who represents the Silicon Valley, echoed FSMB’s words nearly verbatim in a public statement in support of the bill.

    Further, in the way it equates mis- and disinformation with professional misconduct, AB 2098 has much in common with The Disinformation Dozen, a 2021 report issued by the UK-based Center for Countering Digital Hate. This document contended that 12 prominent online influencers—including several vaccine-critical physicians—are responsible for the majority of all anti-vax content on social media. 

    The Disinformation Dozen report conflated COVID-19 misinformation with online hate-mongering, misogyny, racism, anti-LBGTQ attitudes, and promotion of anti-science views. The document served as the basis for a federal government attempt to coerce Facebook to block the accounts of those named in the report.

    A Measure of Protection

    According to Jaffe, Judge Shubb’s injunction provides protection—at least temporarily—for the physicians named in the Hoang and Høeg cases, as well as for physician members of PIC and CHD, the organizations named in the Hoang case.

    In general, though, he stressed that physicians in California need to be very careful about what they say, and especially about what they post online pertaining to COVID, vaccines, off-label uses for prescription drugs, use of supplements, and other hot-button regulatory issues.

    As written, AB 2098 only applies to MDs and DOs licensed in California. Jaffe said that for the moment, nurses, naturopaths, chiropractors, practitioners of oriental medicine, and other practitioner groups have a relative degree of safety—because they are not under the jurisdiction of California’s medical or osteopathic boards.

    On one level, the fight over AB 2098 is a local issue. But it has significant national ramifications, especially given the agenda-setting role of the FSMB, and the fact that other states are considering similar laws.

    Everyone in the natural products industry ought to pay close attention to what’s happening in California. It may not seem imminently threatening to your own life or business. But seen in the context of broader efforts to squelch dialog about non-prescription alternatives, and to limit the public’s access to supplements, the fight over AB 2098 is definitely cause for concern.


    About the Author: Erik Goldman is co-founder and editor of Holistic Primary Care: News for Health & Healing, a quarterly medical publication reaching about 60,000 physicians and other healthcare professionals nationwide.
    Related Searches
    • Regulations
    • Dietary Supplements
    • Healthcare Trends
    • Medical Nutrition
    Related Knowledge Center
    • Healthcare Trends
    • Dietary Supplements
    • Medical Nutrition
    • Regulations
      Loading, Please Wait..
      Trending
      • Shiitake Mushroom Extract Appears Helpful In HPV Infections
      • The Functional Chocolate Company Launches Painfree Chocolate
      • Amazon Bans Dietary Supplements Containing NMN
      Breaking News
      • GOOD Meat Receives FDA Go-Ahead for Cultured Meat
      • IFF Achieves Industrial-Scale Production of Anaerobic Probiotic Strain
      • Jones Healthcare Group Primed to Help Nutraceutical Brands Comply with New Packaging Rules
      • Nordic Naturals Debuts Probiotic Line in More Than 375 Sprouts Farmer’s Markets
      • DolCas Biotech's Curcugen Featured in Beauty-From-Within Supplement
      View Breaking News >
      CURRENT ISSUE

      March 2023

      • Supporting Musculoskeletal Health: Tending to Muscles, Joints, and Bones
      • Dosage and Delivery Innovations Help Manufacturers Meet Common Challenges
      • 2023 Contract Manufacturing Survey
      • Manufacturing Dietary Supplements in Economic Uncertainty
      • Beyond Antioxidants: The Power of Berries
      • A Paradigm Shift for Antioxidants?
      • Ayana Bio on Path to Scale Bioactives Derived from Plant Cell Cultures
      • Nuritas: Leveraging Artificial Intelligence to Speak the Language of Life
      • Dietary Supplement Quality Assurance Programs Critical to Natural Products Industry Success
      • Innovation in Nutraceuticals: Dose Forms and Application Science Help Meet Consumer Demand
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      GOOD Meat Receives FDA Go-Ahead for Cultured Meat
      IFF Achieves Industrial-Scale Production of Anaerobic Probiotic Strain
      Jones Healthcare Group Primed to Help Nutraceutical Brands Comply with New Packaging Rules
      Coatings World

      Latest Breaking News From Coatings World

      Sherwin-Williams Wins Three AMPP Awards
      OQ Chemicals Reduces CO2 Emissions at Bay City, Texas Plant by 10% in 2022
      Perstorp Strengthens Sustainable Offerings
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      First European Use of CairnSurgical's Breast Cancer Locator System
      Healthcare AI Specialist, SensorsCall Join Forces on Home Monitoring Tech
      Victoria Carr-Brendel Joins Vicarious Surgical Board
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Aenova Names Roel de Nobel Head of Business Unit Solids
      Macomics, Ono Pharmaceutical Partner to Develop Immuno-oncology Antibody Drugs
      Dupixent Trial Demonstrates Potential to be First Biologic to Treat COPD
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      The RealReal Discontinues Beauty Business
      Tree Hut Announces Pop-Up Experience in NYC
      Puig’s Net Revenue Grows 40% to Over $3.9 Billion in 2022
      Happi

      Latest Breaking News From Happi

      Mary Kay's Topical with Vinca Major Provides Reduction of Melanin Production
      Gojo Industries Announces Next Phase of its Sustainable Value Strategy
      Puig Exceeds $3.89 Billion in Revenues for 2022
      Ink World

      Latest Breaking News From Ink World

      Roland DGA to Showcase Latest Technologies at ISA 2023
      hubergroup India Expands Support for Rural Healthcare
      Toyo Ink Shareholders Approve Trade Name Change to artience
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      TLMI announces 2022 Eugene Singer Award winners
      Pulse Roll Label Products expands technical sales team
      Mark Andy introduces ProWORX Label Suite
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Heartland Polymers Begins Production in Alberta
      Zeta Polimeri Becomes Radici EcoMaterials
      Responsible Flushing Alliance Holds Annual Meeting
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      3D LifePrints Rebrands to Insight Surgery & Launches New Business in Houston
      Companion Spine Closes $60.1 Million Series A Funding Round
      Missouri Neurosurgeon Settles Federal Kickback Lawsuit for $825K
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      HID Reports on Reshaping the Security Industry
      Meyers Introduces New Function47 Division
      Global Fab Equipment Spending on Track for 2024 Recovery: SEMI

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login